These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3825177)

  • 1. Disposition of new sulphur-containing 2-(chloroethyl)nitrosoureas in rats.
    Godenèche D; Madelmont JC; Labarre P; Plagne R; Meyniel G
    Xenobiotica; 1987 Jan; 17(1):59-70. PubMed ID: 3825177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytostatic action of two nitrosoureas derived from cysteamine.
    Bourut C; Chenu E; Godenèche D; Madelmont JC; Maral R; Mathé G; Meyniel G
    Br J Pharmacol; 1986 Nov; 89(3):539-46. PubMed ID: 3801787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Main urinary metabolites of two cysteamine-containing 2-(chloroethyl) nitrosoureas in rats.
    Godeneche D; Labarre P; Moreau MF; Madelmont JC; Rapp M; Papon J; Veyre A
    Drug Metab Dispos; 1993; 21(1):93-9. PubMed ID: 8095233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA damage induced by a new 2-chloroethyl nitrosourea on malignant melanoma cells.
    Godeneche D; Rapp M; Thierry A; Laval F; Madelmont JC; Chollet P; Veyre A
    Cancer Res; 1990 Sep; 50(18):5898-903. PubMed ID: 2393861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical structure of carbamoylating groups and their relationship to bone marrow toxicity and antiglioma activity of bifunctionally alkylating and carbamoylating nitrosoureas.
    Ali-Osman F; Giblin J; Berger M; Murphy MJ; Rosenblum ML
    Cancer Res; 1985 Sep; 45(9):4185-91. PubMed ID: 2411398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition and metabolism in 1-(2-chloroethyl)-3-(2',3',4'-tri-o-acetyl, ribopyranosyl)-1-nitrosourea in rats.
    Godeneche D; Moreau MF; Madelmont JC; Duprat J; Plagne R
    Cancer Res; 1982 Feb; 42(2):525-9. PubMed ID: 6799188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of 1-(2-chloroethyl)-1-nitrosourea activity at the cellular level.
    Weinkam RJ; Dolan ME
    J Med Chem; 1983 Nov; 26(11):1656-9. PubMed ID: 6226795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New cysteamine (2-chloroethyl)nitrosoureas. Synthesis and preliminary antitumor results.
    Madelmont JC; Godeneche D; Parry D; Duprat J; Chabard JL; Plagne R; Mathe G; Meyniel G
    J Med Chem; 1985 Sep; 28(9):1346-50. PubMed ID: 4032435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cell cycle position on the survival of 9L cells treated with nitrosoureas that alkylate, cross-link, and carbamoylate.
    Linfoot PA; Gray JW; Dean PN; Marton LJ; Deen DF
    Cancer Res; 1986 May; 46(5):2402-6. PubMed ID: 3697983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A method to determine the carbamoylating potential of 1-(2-chloroethyl)-1-nitrosoureas.
    Stahl W; Krauth-Siegel RL; Schirmer RH; Eisenbrand G
    IARC Sci Publ; 1987; (84):191-3. PubMed ID: 2960614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA sequence selectivity of guanine-N7 alkylation by three antitumor chloroethylating agents.
    Hartley JA; Gibson NW; Kohn KW; Mattes WB
    Cancer Res; 1986 Apr; 46(4 Pt 2):1943-7. PubMed ID: 3004713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological disposition of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea in mice.
    Rahman A; Luc PV; Schein PS; Woolley PV
    Cancer Res; 1984 Jan; 44(1):149-53. PubMed ID: 6690033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug design: nitrosoureas.
    Eisenbrand G; Müller N; Schreiber J; Stahl W; Sterzel W; Berger MR; Zeller WJ; Fiebig H
    IARC Sci Publ; 1986; (78):281-94. PubMed ID: 3583393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control over the sequence specificity of DNA alkylation: syntheses and reactions with 32P-end-labelled DNA of N-alkyl-N-nitrosoureas linked to minor groove binding lexitropsins.
    Gold B; Church KM; Wurdeman RL; Zhang Y; Chen FX
    IARC Sci Publ; 1991; (105):439-42. PubMed ID: 1649793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxyethylation of hemoglobin by 1-(2-chloroethyl)-1-nitrosoureas.
    Bailey E; Farmer PB; Tang YS; Vangikar H; Gray A; Slee D; Ings RM; Campbell DB; McVie JG; Dubbelman R
    Chem Res Toxicol; 1991; 4(4):462-6. PubMed ID: 1912334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic disposition of 2-chloroethyl nitrosocarbamoylcystamine in rats.
    Godeneche D; Madelmont JC; Moreau MF; Duprat J; Chabard JL; Plagne R; Meyniel G
    Drug Metab Dispos; 1985; 13(2):220-6. PubMed ID: 2859172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathways and kinetics of aqueous decomposition and carbamoylating activity of new anticancer nitroimidazole-linked 2-chloroethylnitrosoureas.
    Carminati A; Barascut JL; Naghipur A; Lown JW; Imbach JL
    Biochem Pharmacol; 1989 Jul; 38(14):2253-8. PubMed ID: 2751691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitroso urea hydrochloride with nucleic acids and proteins.
    Nishigaki T; Tanaka M
    Chem Biol Interact; 1985 Dec; 56(2-3):213-24. PubMed ID: 2416482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I trial of Perrimustine, a new cysteamine (2-chloroethyl) nitrosourea: an intrapatient escalation scheme.
    Kim-Triana B; Misset JL; Madelmont JC; Godenèche D; Musset M; Mathé G
    Anticancer Drugs; 1992 Jun; 3(3):225-31. PubMed ID: 1525402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antitumor activity of some new 2-chloroethylnitrosoureas.
    Filippatos E; Papadaki-Valiraki A; Roussakis C; Verbist JF
    Arch Pharm (Weinheim); 1993 Aug; 326(8):451-6. PubMed ID: 8215842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.